Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Public Health

Sec. Infectious Diseases: Epidemiology and Prevention

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1620930

Epidemiological and molecular analysis of anthrax cases of the Zhambyl region Kazakhstan in 2023

Provisionally accepted
Uinkul  IzbanovaUinkul IzbanovaAltyn  RysbekovaAltyn RysbekovaZauresh  ZhumadilovaZauresh ZhumadilovaGalina  KovalevaGalina KovalevaGulnara  TokmurziyevaGulnara TokmurziyevaBek  AbdelBek AbdelDuman  YessimseitDuman YessimseitElmira  BegimbayevaElmira BegimbayevaSaule  UmarovaSaule UmarovaAnar  ZarkymanovaAnar ZarkymanovaMeruert  SabitovaMeruert SabitovaAisazhan  YussupovAisazhan YussupovSvetlana  IsaevaSvetlana IsaevaNur  TukhanovaNur Tukhanova*
  • M. Aikimbaev National Research Center for Especially Dangerous Infections, Almaty, Kazakhstan

The final, formatted version of the article will be published soon.

Background: Anthrax, caused by Bacillus anthracis, continues to pose a serious zoonotic threat in endemic areas such as southern Kazakhstan. Its persistence in the environment through resilient spores facilitates prolonged transmission cycles between animals and humans.Objective: This study aimed to characterize the epidemiological, clinical, and molecular features of human anthrax cases reported in the Zhambyl region of Kazakhstan during 2023.Methods: A total of 41 suspected cases were investigated, of which 19 were confirmed by culture and PCR (targeting pXO1 and pXO2). Data collection included patient demographics, exposure circumstances, clinical manifestations, and laboratory diagnostics. MLVA-31 genotyping was used to characterize B. anthracis isolates from culture-positive patients.Results: Confirmed cases were clustered in five district localities, yielding an incidence rate of 1.55 per 100,000 population. The majority of patients were male (84.2%), with exposure primarily linked to slaughter activities (68.4%). Culture was successful in 12 of 19 confirmed cases, and all isolates were susceptible to a broad range of antibiotics, including ciprofloxacin and doxycycline. Genotyping revealed three distinct clusters: one matching the A.Br.001/002 genotype common to northeastern China and Mongolia, and two divergent clusters likely represent localized evolution of B. anthracis strains. Five previously undocumented foci of anthrax were identified, suggesting wider regional spread than previously recognized.The 2023 outbreak of anthrax in the Zhambyl region highlights the ongoing risk posed by B. anthracis, particularly in areas with active livestock trade and conducive environmental conditions. The genetic diversity among isolates suggests both recent transmission and deeper endemic roots. Strengthening livestock vaccination programs, improving rural surveillance, and promoting awareness among high-risk populations are critical to preventing future outbreaks.

Keywords: Anthrax, Monitoring, Epizootic, Strain, stationary unfavorable point, Kazakhstan

Received: 30 Apr 2025; Accepted: 09 Jul 2025.

Copyright: © 2025 Izbanova, Rysbekova, Zhumadilova, Kovaleva, Tokmurziyeva, Abdel, Yessimseit, Begimbayeva, Umarova, Zarkymanova, Sabitova, Yussupov, Isaeva and Tukhanova. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Nur Tukhanova, M. Aikimbaev National Research Center for Especially Dangerous Infections, Almaty, Kazakhstan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.